Food & Drug Administration (FDA) Archives - Page 231 of 509 - MassDevice
Teva receives warning letter over Actavis site
Teva Recalls Drug Vials, Shuts Facility Over Mold Concerns - TheStreet
Teva settles with Roche to launch first Rituxan biosimilar in US - BioProcess InternationalBioProcess International
Adam Hricz - Associate Director, Commercial Supply Chain Hungary - Teva Pharmaceuticals | LinkedIn
Teva Reports Second Quarter 2020 Financial Results | Business Wire
India 2019 – R&D Highs, Compliance Woes And Other Lows :: Pink Sheet
Teva останавливает работу американского завода после проверки FDA » Фармвестник
Teva receives warning letter over Actavis site
Teva Stops Production At US Plant After FDA Concerns: Report
Teva partners with Just Biotherapeutics, ramping up biologics productivity - BioProcess InsiderBioProcess International
Teva's rating cut to junk, Two Lupin facilities receive FDA warning letters | Radio Compass Blog
Teva two: FDA approves Celltrion-made Herceptin biosimilar - BioProcess InternationalBioProcess International
Celltrion slammed with US FDA warning at biosimilar site
Sanofi begins work on succession plan; FDA issues warning letters to Lupin's US, India units | Radio Compass Blog
Teva Reports Second Quarter 2020 Financial Results | Business Wire
FDA Bans Imports From Teva's Hungary Plant Except Two Drugs in Shortage | RAPS
Analysis of FDA Infrared 483 Citations: Have You a Data Integrity Problem?
FDA cites 'significant' sterility concern at Teva injectables plant | FiercePharma
Aurobindo Receives Warning Letter After Form 483 :: Generics Bulletin
Teva catches break as warning letter looks to delay Momenta Copaxone generic | FiercePharma
Generic Drug Giant Recalls Millions of Drugs Over Mold Concerns • Drugwatcher.org
Teva confident in September approval for migraine drug despite latest Celltrion plant citation | FiercePharma
UPDATED: FDA Issues CLRs for Two Celltrion and Teva Biosimilars | BioSpace
Biosimilar… but different: FDA tweaking nonproprietary name guidance - BioProcess InternationalBioProcess International
